MEK1/2-ERK Pathway Alterations as a Therapeutic Target in Sporadic Alzheimer’s Disease: A Study in Senescence-Accelerated OXYS Rats

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia worldwide, with no cure. There is growing interest in mitogen-activated protein kinases (MAPKs) as possible pathogenesis-related therapeutic targets in AD. Previously, using senescence-accelera...

Descripción completa

Detalles Bibliográficos
Autores principales: Muraleva, Natalia A., Kolosova, Nataliya G., Stefanova, Natalia A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300733/
https://www.ncbi.nlm.nih.gov/pubmed/34208998
http://dx.doi.org/10.3390/antiox10071058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300733/
https://www.ncbi.nlm.nih.gov/pubmed/34208998
http://dx.doi.org/10.3390/antiox10071058

Ejemplares similares